Tuesday, December 29, 2020

Zydus Cadila receives DCGI nod for NAFLD drug in India

Zydus Cadila receives DCGI nod for NAFLD drug in India The Drug Controller General of India (DCGI) has approved the new drug application (NDA) for Saroglitazar Mg for the treatment of non-alcoholic fatty liver disease (NAFLD) in India, Zydus Cadila said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2MjQTfu

No comments:

Post a Comment

Tariffs a temporary storm, structural reforms key for India: Arvind Sanger

Arvind Sanger of Geosphere Capital Management suggests a trade deal with the U.S. would benefit India by reducing market uncertainty and pro...